Longitudinal Lipid Changes During 144-week PegIFNα-based Therapy in Chronic Hepatitis B: A Retrospective Cohort Study
Pegylated interferon alpha (PegIFNα) has been associated with altered lipid metabolism, but long-term lipid trajectories in chronic hepatitis B remain poorly characterized. We evaluated lipid profiles and virological parameters during 144 weeks of PegIFNα-based therapy.
Authors
- Ahmad Faiza
- Yi Liu (ORCID: https://orcid.org/0000-0001-6874-4709)
- Feng Ye (ORCID: https://orcid.org/0000-0003-1418-7980)
- Fangfang Li
- Keyang Dong
- S. Abdulaziz Abdulgani
- Liping Zuo
- Li Ma
- Siyao Wang
- Zhan Qu
- Rehman Shahab
- Jing Li
Publication Details
- Journal
- Journal of Translational Gastroenterology
- Published
- 2026-10-28
- DOI
- https://doi.org/10.14218/jtg.2026.00031
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00